Research

Faculty Research Interests by Department

The College of Pharmacy’s Core for Drug Analysis and Development (CDAD) is dedicated to bridging between basic discovery research and clinical development of drugs and medical devices. 

Analytical support is provided on an at-cost basis to maintain projects with extramural research funding or established Maine-based companies.  Seed support is provided on a pro bono basis to Maine-based institutions for early-stage projects with potential to lead to extramural funding or commercialization.  

By providing the necessary link between basic and applied efforts, we hope to facilitate drug development in Maine and to ensure that all promising discoveries are translated into new products.  At the same time the College of Pharmacy will develop new strategies for improving individualized pharmaceutical and nutraceutical care.

The research mission of the College of Pharmacy has been greatly accelerated by a $4 million grant from the Maine Technology Asset Fund (MTAF 1016) that Governor John Baldacci announced on Aug. 11, 2008.  

Research faculty associated with the College of Pharmacy's CDAD will bring approximately $600,000 to Maine in extramural grant support for the 2010-2011 academic year.  

On May 28, 2010, there was an external review of the research program supported by MTAF 1016.  This review was conducted by a Scientific Advisory Board comprised of distinguished scientists from academia and industry.  The board will help to guide further development of the College of Pharmacy research program.